Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021
This article introduces the fourth update of the Australian and New Zealand consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting. These guidelines are comprised of nine articles as presented in this special issue of the I...
Gespeichert in:
| Veröffentlicht in: | Internal medicine journal 2021-11, Vol.51 (S7), p.3-17 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 17 |
|---|---|
| container_issue | S7 |
| container_start_page | 3 |
| container_title | Internal medicine journal |
| container_volume | 51 |
| creator | Chang, Christina C. Blyth, Christopher C. Chen, Sharon C‐A. Khanina, Anna Morrissey, C. Orla Roberts, Jason A. Thursky, Karin A. Worth, Leon J. Slavin, Monica A. |
| description | This article introduces the fourth update of the Australian and New Zealand consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting. These guidelines are comprised of nine articles as presented in this special issue of the Internal Medicine Journal. This introductory chapter outlines the rationale for the current update and the steps taken to ensure implementability in local settings. Given that 7 years have passed since the previous iteration of these guidelines, pertinent contextual changes that impacted guideline content and recommendations are discussed, including the evolution of invasive fungal disease (IFD) definitions. We also outline our approach to guideline development, evidence grading, review and feedback. Highlights of the 2021 update are presented, including expanded scope to provide more detailed coverage of common and emerging fungi such as Aspergillus and Candida species, and emerging fungi, and a greater focus on the principles of antifungal stewardship. We also introduce an entirely new chapter dedicated to helping healthcare workers convey important concepts related to IFD, infection prevention and antifungal therapy, to patients. |
| doi_str_mv | 10.1111/imj.15585 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2613290909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2612460990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-1cc7ccf40b554f1e9c4c2b722813366036b5317e87cdb931f59c904dbe14bc8a3</originalsourceid><addsrcrecordid>eNp1kctu1DAUhi0EomVgwQsgS2xAIh07tpN4WVVcBhWxgXXk2CepR4k9-FI0r8UT4mYGFkh4c47k7_9k-UfoJSVXtJytXfZXVIhOPEKXlHNRCSn543XnFZGEXaBnMe4JoS2T_Cm6YFyyljJxiX7tXAreZJ2sdzh5nO4A54NRCQy-zjEFNatolcPauwgu5oinbA3M1kHEow9rYlFOTbCAS9iP2Lr7krkHPGY3qRkbG0FFwMoZnMssiHLJnm9L0KVYQqvpTsGikp_9dNx6p9cFR0jJuukdrklNn6Mno5ojvDjPDfr-4f23m0_V7dePu5vr20qzrhMV1brVeuRkEIKPFKTmuh7auu4oY01DWDMIRlvoWm0GyegopJaEmwEoH3Sn2Aa9OXkPwf_IEFO_2KhhnpUDn2NfN5TVsnyvLOjrf9C9z8GV1z1QNW-ILC1s0NsTpYOPMcDYH4JdVDj2lPQPRfalyH4tsrCvzsY8LGD-kn-aK8D2BPy0Mxz_b-p3Xz6flL8BUJWqaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612460990</pqid></control><display><type>article</type><title>Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Chang, Christina C. ; Blyth, Christopher C. ; Chen, Sharon C‐A. ; Khanina, Anna ; Morrissey, C. Orla ; Roberts, Jason A. ; Thursky, Karin A. ; Worth, Leon J. ; Slavin, Monica A.</creator><creatorcontrib>Chang, Christina C. ; Blyth, Christopher C. ; Chen, Sharon C‐A. ; Khanina, Anna ; Morrissey, C. Orla ; Roberts, Jason A. ; Thursky, Karin A. ; Worth, Leon J. ; Slavin, Monica A. ; Australasian Antifungal Guidelines Steering Committee ; Australasian Antifungal Guidelines Steering Committee</creatorcontrib><description>This article introduces the fourth update of the Australian and New Zealand consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting. These guidelines are comprised of nine articles as presented in this special issue of the Internal Medicine Journal. This introductory chapter outlines the rationale for the current update and the steps taken to ensure implementability in local settings. Given that 7 years have passed since the previous iteration of these guidelines, pertinent contextual changes that impacted guideline content and recommendations are discussed, including the evolution of invasive fungal disease (IFD) definitions. We also outline our approach to guideline development, evidence grading, review and feedback. Highlights of the 2021 update are presented, including expanded scope to provide more detailed coverage of common and emerging fungi such as Aspergillus and Candida species, and emerging fungi, and a greater focus on the principles of antifungal stewardship. We also introduce an entirely new chapter dedicated to helping healthcare workers convey important concepts related to IFD, infection prevention and antifungal therapy, to patients.</description><identifier>ISSN: 1444-0903</identifier><identifier>EISSN: 1445-5994</identifier><identifier>DOI: 10.1111/imj.15585</identifier><identifier>PMID: 34937135</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Antifungal agents ; Antifungal Agents - therapeutic use ; antifungal prophylaxis ; antifungal therapy ; Aspergillus ; Australia ; Disease management ; Fungal diseases ; haematological malignancy ; Hematology ; Humans ; invasive fungal disease ; Invasive Fungal Infections - drug therapy ; Invasive Fungal Infections - microbiology ; Medical Oncology ; Medical personnel ; Oncology ; treatment guideline</subject><ispartof>Internal medicine journal, 2021-11, Vol.51 (S7), p.3-17</ispartof><rights>2021 Royal Australasian College of Physicians</rights><rights>2021 Royal Australasian College of Physicians.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-1cc7ccf40b554f1e9c4c2b722813366036b5317e87cdb931f59c904dbe14bc8a3</citedby><cites>FETCH-LOGICAL-c3885-1cc7ccf40b554f1e9c4c2b722813366036b5317e87cdb931f59c904dbe14bc8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fimj.15585$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fimj.15585$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34937135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Christina C.</creatorcontrib><creatorcontrib>Blyth, Christopher C.</creatorcontrib><creatorcontrib>Chen, Sharon C‐A.</creatorcontrib><creatorcontrib>Khanina, Anna</creatorcontrib><creatorcontrib>Morrissey, C. Orla</creatorcontrib><creatorcontrib>Roberts, Jason A.</creatorcontrib><creatorcontrib>Thursky, Karin A.</creatorcontrib><creatorcontrib>Worth, Leon J.</creatorcontrib><creatorcontrib>Slavin, Monica A.</creatorcontrib><creatorcontrib>Australasian Antifungal Guidelines Steering Committee</creatorcontrib><creatorcontrib>Australasian Antifungal Guidelines Steering Committee</creatorcontrib><title>Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021</title><title>Internal medicine journal</title><addtitle>Intern Med J</addtitle><description>This article introduces the fourth update of the Australian and New Zealand consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting. These guidelines are comprised of nine articles as presented in this special issue of the Internal Medicine Journal. This introductory chapter outlines the rationale for the current update and the steps taken to ensure implementability in local settings. Given that 7 years have passed since the previous iteration of these guidelines, pertinent contextual changes that impacted guideline content and recommendations are discussed, including the evolution of invasive fungal disease (IFD) definitions. We also outline our approach to guideline development, evidence grading, review and feedback. Highlights of the 2021 update are presented, including expanded scope to provide more detailed coverage of common and emerging fungi such as Aspergillus and Candida species, and emerging fungi, and a greater focus on the principles of antifungal stewardship. We also introduce an entirely new chapter dedicated to helping healthcare workers convey important concepts related to IFD, infection prevention and antifungal therapy, to patients.</description><subject>Antifungal agents</subject><subject>Antifungal Agents - therapeutic use</subject><subject>antifungal prophylaxis</subject><subject>antifungal therapy</subject><subject>Aspergillus</subject><subject>Australia</subject><subject>Disease management</subject><subject>Fungal diseases</subject><subject>haematological malignancy</subject><subject>Hematology</subject><subject>Humans</subject><subject>invasive fungal disease</subject><subject>Invasive Fungal Infections - drug therapy</subject><subject>Invasive Fungal Infections - microbiology</subject><subject>Medical Oncology</subject><subject>Medical personnel</subject><subject>Oncology</subject><subject>treatment guideline</subject><issn>1444-0903</issn><issn>1445-5994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctu1DAUhi0EomVgwQsgS2xAIh07tpN4WVVcBhWxgXXk2CepR4k9-FI0r8UT4mYGFkh4c47k7_9k-UfoJSVXtJytXfZXVIhOPEKXlHNRCSn543XnFZGEXaBnMe4JoS2T_Cm6YFyyljJxiX7tXAreZJ2sdzh5nO4A54NRCQy-zjEFNatolcPauwgu5oinbA3M1kHEow9rYlFOTbCAS9iP2Lr7krkHPGY3qRkbG0FFwMoZnMssiHLJnm9L0KVYQqvpTsGikp_9dNx6p9cFR0jJuukdrklNn6Mno5ojvDjPDfr-4f23m0_V7dePu5vr20qzrhMV1brVeuRkEIKPFKTmuh7auu4oY01DWDMIRlvoWm0GyegopJaEmwEoH3Sn2Aa9OXkPwf_IEFO_2KhhnpUDn2NfN5TVsnyvLOjrf9C9z8GV1z1QNW-ILC1s0NsTpYOPMcDYH4JdVDj2lPQPRfalyH4tsrCvzsY8LGD-kn-aK8D2BPy0Mxz_b-p3Xz6flL8BUJWqaQ</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Chang, Christina C.</creator><creator>Blyth, Christopher C.</creator><creator>Chen, Sharon C‐A.</creator><creator>Khanina, Anna</creator><creator>Morrissey, C. Orla</creator><creator>Roberts, Jason A.</creator><creator>Thursky, Karin A.</creator><creator>Worth, Leon J.</creator><creator>Slavin, Monica A.</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021</title><author>Chang, Christina C. ; Blyth, Christopher C. ; Chen, Sharon C‐A. ; Khanina, Anna ; Morrissey, C. Orla ; Roberts, Jason A. ; Thursky, Karin A. ; Worth, Leon J. ; Slavin, Monica A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-1cc7ccf40b554f1e9c4c2b722813366036b5317e87cdb931f59c904dbe14bc8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antifungal agents</topic><topic>Antifungal Agents - therapeutic use</topic><topic>antifungal prophylaxis</topic><topic>antifungal therapy</topic><topic>Aspergillus</topic><topic>Australia</topic><topic>Disease management</topic><topic>Fungal diseases</topic><topic>haematological malignancy</topic><topic>Hematology</topic><topic>Humans</topic><topic>invasive fungal disease</topic><topic>Invasive Fungal Infections - drug therapy</topic><topic>Invasive Fungal Infections - microbiology</topic><topic>Medical Oncology</topic><topic>Medical personnel</topic><topic>Oncology</topic><topic>treatment guideline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Christina C.</creatorcontrib><creatorcontrib>Blyth, Christopher C.</creatorcontrib><creatorcontrib>Chen, Sharon C‐A.</creatorcontrib><creatorcontrib>Khanina, Anna</creatorcontrib><creatorcontrib>Morrissey, C. Orla</creatorcontrib><creatorcontrib>Roberts, Jason A.</creatorcontrib><creatorcontrib>Thursky, Karin A.</creatorcontrib><creatorcontrib>Worth, Leon J.</creatorcontrib><creatorcontrib>Slavin, Monica A.</creatorcontrib><creatorcontrib>Australasian Antifungal Guidelines Steering Committee</creatorcontrib><creatorcontrib>Australasian Antifungal Guidelines Steering Committee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Internal medicine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Christina C.</au><au>Blyth, Christopher C.</au><au>Chen, Sharon C‐A.</au><au>Khanina, Anna</au><au>Morrissey, C. Orla</au><au>Roberts, Jason A.</au><au>Thursky, Karin A.</au><au>Worth, Leon J.</au><au>Slavin, Monica A.</au><aucorp>Australasian Antifungal Guidelines Steering Committee</aucorp><aucorp>Australasian Antifungal Guidelines Steering Committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021</atitle><jtitle>Internal medicine journal</jtitle><addtitle>Intern Med J</addtitle><date>2021-11</date><risdate>2021</risdate><volume>51</volume><issue>S7</issue><spage>3</spage><epage>17</epage><pages>3-17</pages><issn>1444-0903</issn><eissn>1445-5994</eissn><abstract>This article introduces the fourth update of the Australian and New Zealand consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting. These guidelines are comprised of nine articles as presented in this special issue of the Internal Medicine Journal. This introductory chapter outlines the rationale for the current update and the steps taken to ensure implementability in local settings. Given that 7 years have passed since the previous iteration of these guidelines, pertinent contextual changes that impacted guideline content and recommendations are discussed, including the evolution of invasive fungal disease (IFD) definitions. We also outline our approach to guideline development, evidence grading, review and feedback. Highlights of the 2021 update are presented, including expanded scope to provide more detailed coverage of common and emerging fungi such as Aspergillus and Candida species, and emerging fungi, and a greater focus on the principles of antifungal stewardship. We also introduce an entirely new chapter dedicated to helping healthcare workers convey important concepts related to IFD, infection prevention and antifungal therapy, to patients.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>34937135</pmid><doi>10.1111/imj.15585</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1444-0903 |
| ispartof | Internal medicine journal, 2021-11, Vol.51 (S7), p.3-17 |
| issn | 1444-0903 1445-5994 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2613290909 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Antifungal agents Antifungal Agents - therapeutic use antifungal prophylaxis antifungal therapy Aspergillus Australia Disease management Fungal diseases haematological malignancy Hematology Humans invasive fungal disease Invasive Fungal Infections - drug therapy Invasive Fungal Infections - microbiology Medical Oncology Medical personnel Oncology treatment guideline |
| title | Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T13%3A10%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Introduction%20to%20the%20updated%20Australasian%20consensus%20guidelines%20for%20the%20management%20of%20invasive%20fungal%20disease%20and%20use%20of%20antifungal%20agents%20in%20the%20haematology/oncology%20setting,%202021&rft.jtitle=Internal%20medicine%20journal&rft.au=Chang,%20Christina%20C.&rft.aucorp=Australasian%20Antifungal%20Guidelines%20Steering%20Committee&rft.date=2021-11&rft.volume=51&rft.issue=S7&rft.spage=3&rft.epage=17&rft.pages=3-17&rft.issn=1444-0903&rft.eissn=1445-5994&rft_id=info:doi/10.1111/imj.15585&rft_dat=%3Cproquest_cross%3E2612460990%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2612460990&rft_id=info:pmid/34937135&rfr_iscdi=true |